Viewpoints

Opinion and analysis on managing care from experts and KOLs

Contributing Voices
Nathan White, Adam Johns, and Eric Latch
A few years ago, if you had mentioned ICER, even pharma industry insiders wouldn’t know what you were talking about—or would have confused it with confirmation of naval orders (aye, sir!). Now ICER—the acronym for the Institute for Clinical and Economic Review—has become familiar to anyone involved…
Viewpoint
François de Brantes
Public opposition would be unseemly, so insurers and hospitals work behind the scenes against price transparency.
Viewpoint
Jennifer Bright
Mark Linthicum
The “waste-free formulary” under development by the Pacific Business Group on Health sounds promising, but ultimately may not deliver the impact to self-insured employers its creators are promising. The approach glosses over a critical question: What constitutes “high-value”? The definition of value plays a central role in determining the care that patients ultimately receive.
Viewpoint
Maggie Alston
Bruce Pyenson
First of two parts An alternative payment model (APM) is a nontraditional financial arrangement that rewards health care providers who deliver cost-effective, high-quality care. APMs facilitate the sharing of risk between health care provider organizations and insurers for the cost and quality of care…
Viewpoint
Laurie Golemi Norman, MSN, APRN
HEIP stands for hospital efficiency improvement program. It is a legal contract outlining specific initiatives where physician-driven variance can be improved across specialties and departments. For organizations with a good strategy to reduce care variation, a HEIP can provide the jolt of incentive that generates real improvement.
Viewpoint
Craig Kasten
Health care is increasingly becoming like other retail encounters—a transaction between buyers and sellers. Patients, providers, payers—everybody needs to adjust. With the right technology and the will to change, the process of paying for health care can become as simple—and as painless—as getting a haircut.
Viewpoint
Zachary Hafner
At last count, the pharmaceutical industry’s new product pipeline included more than 7,000 products in late-stage development, roughly half of which are deemed “specialty.” The reality is, our health care system is poorly equipped to address this issue head-on.
Viewpoint
François de Brantes
It’s no mystery why this country has both the highest per capita health care costs and the lowest overall percentage of people with coverage. The two are connected, but as if on a teeter-tooter: As one goes up, the other goes down.